Provided by Tiger Trade Technology Pte. Ltd.

Integra Lifesciences

13.56
+0.14501.08%
Volume:532.12K
Turnover:7.18M
Market Cap:1.06B
PE:-145.57
High:13.86
Open:13.86
Low:13.24
Close:13.41
52wk High:20.49
52wk Low:8.70
Shares:77.89M
Float Shares:58.67M
Volume Ratio:0.32
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0931
EPS(LYR):-6.7400
ROE:-0.70%
ROA:2.82%
PB:1.01
PE(LYR):-2.01

Loading ...

May 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 06, 2024

Major Issues Report

Form 8-K - Current report
Mar 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 21, 2023

Major Issues Report

Form 8-K - Current report
Dec 13, 2023

Major Issues Report

Form 8-K - Current report
Dec 13, 2023

Major Issues Report

Form 8-K - Current report
Oct 25, 2023

Major Issues Report

Form 8-K - Current report
Oct 25, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 16, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 28, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 27, 2023

Major Issues Report

Form 8-K - Current report
Jun 21, 2023

Major Issues Report

Form 8-K - Current report